Literature DB >> 13138711

Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis.

J T ELLIS, I SCHULMAN, C H SMITH.   

Abstract

Entities:  

Keywords:  ANEMIA, ERYTHROBLASTIC/complications; LIVER/diseases; PANCREAS/diseases; SIDEROSIS

Mesh：

Year:  1954        PMID： 13138711      PMCID： PMC1942465     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  7 in total

1.  Development of pigmentary cirrhosis in Cooley's anemia.

Authors:  J HOWELL; J P WYATT
Journal:  AMA Arch Pathol       Date:  1953-05

2.  Experimental induction of iron overload in the rat. I. Morphological alterations due to dietary siderosis.

Authors:  J P WYATT; J HOWELL
Journal:  AMA Arch Pathol       Date:  1953-06

3.  Hemochromatosis after prolonged oral iron therapy in a patient with chronic hemolytic anemia.

Authors:  R O WALLERSTEIN; S L ROBBINS
Journal:  Am J Med       Date:  1953-02       Impact factor: 4.965

4.  Exogenous hemochromatosis in Mediterranean anemia.

Authors:  A M FRUMIN; S WALDMAN; P MORRIS
Journal:  Pediatrics       Date:  1952-03       Impact factor: 7.124

5.  Transfusional siderosis.

Authors:  J P WYATT; H K MIGHTON; V MORAGUES
Journal:  Am J Pathol       Date:  1950-09       Impact factor: 4.307

6.  Iron metabolism; the pathophysiology of iron storage.

Authors:  C A FINCH; M HEGSTED; T D KINNEY; E D THOMAS; C E RATH; D HASKINS; S FINCH; R G FLUHARTY
Journal:  Blood       Date:  1950-11       Impact factor: 22.113

7.  Body Length and Organ Weights of Infants and Children: A Study of the Body Length and Normal Weights of the More Important Vital Organs of the Body between Birth and Twelve Years of Age.

Authors:  J M Coppoletta; S B Wolbach
Journal:  Am J Pathol       Date:  1933-01       Impact factor: 4.307
  7 in total
  20 in total

1.  HOMOZYGOUS THALASSAEMIA IN AN ENGLISH CHILD.

Authors:  J K LLOYD; G A BROWN
Journal:  Arch Dis Child       Date:  1964-12       Impact factor: 3.791

2.  HISTOGENESIS OF THE HEPATIC LESION IN PRIMARY HEMOCHROMATOSIS: WITH CONSIDERATION OF THE PSEUDO-IRON DEFICIENT STATE PRODUCED BY PHLEBOTOMIES.

Authors:  M BLOCK; G MOORE; P WASI; G HAIBY
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

Review 3.  IRON DEFICIENCY AND IRON OVERLOAD.

Authors: 
Journal:  Arch Dis Child       Date:  1965-08       Impact factor: 3.791

4.  Iron excretion in thalassaemia major after administration of chelating agents.

Authors:  R S SMITH
Journal:  Br Med J       Date:  1962-12-15

5.  Endocrinopathy in thalassaemia major.

Authors:  N McIntosh
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

6.  Adrenal glands in beta-thalassemia major: magnetic resonance (MR) imaging features and correlation with iron stores.

Authors:  Eleni Drakonaki; Olympia Papakonstantinou; Thomas Maris; Artemis Vasiliadou; Alex Papadakis; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2005-08-16       Impact factor: 5.315

7.  Lymphocyte changes in beta-thalassaemia major.

Authors:  S Musumeci; G Schiliro; M A Romeo; A Sciotto; A Rosalba; G Pizzarelli
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

8.  Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.

Authors:  M Barry; D M Flynn; E A Letsky; R A Risdon
Journal:  Br Med J       Date:  1974-04-06

9.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

10.  Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major.

Authors:  M F Messina; F Lombardo; A Meo; M Miceli; M Wasniewska; M Valenzise; C Ruggeri; T Arrigo; F De Luca
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.